The FUROSEMIDE INJECTION is a the manufacturer industrial component. Key specifications include special_features: AUTHORIZED SUB FOR NSN 6505-01-525-0326, primary_container_type: VIAL, SINGLE DOSE, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 25, primary_container_content_quantity: 2.000 MILLILITERS. This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-157-5117, indicating validated use in U.S.
government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.
| special_features | AUTHORIZED SUB FOR NSN 6505-01-525-0326 |
| primary_container_type | VIAL, SINGLE DOSE |
| pharmaceutical_vehicle_type | AQUEOUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 25 |
| primary_container_content_quantity | 2.000 MILLILITERS |
| active_medicament_medicinal_strength | 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER |
| part_name_assigned_by_controlling_agency | FUROSEMIDE INJECTION USP 10MG/ML 2ML VIAL 25S |
| NSN | 6505-01-157-5117 |
| PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER |
| PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | FUROSEMIDE INJECTION USP 10MG/ML 2ML VIAL 25S |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
| SPECIAL FEATURES | AUTHORIZED SUB FOR NSN 6505-01-525-0326 |